OPKO Health Total Liabilities 2010-2024 | OPK

OPKO Health total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $853
2024-06-30 $585
2024-03-31 $721
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.140B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $216.048B 99.11
Thermo Fisher Scientific (TMO) United States $205.720B 24.60
Alcon (ALC) Switzerland $44.180B 29.56
Edwards Lifesciences (EW) United States $44.064B 28.51
IDEXX Laboratories (IDXX) United States $37.082B 42.44
DexCom (DXCM) United States $34.912B 54.15
IQVIA Holdings (IQV) United States $34.165B 18.93
Mettler-Toledo (MTD) United States $27.257B 31.66
Waters (WAT) United States $22.611B 32.08
STERIS (STE) Ireland $21.693B 24.81
SONOVA HOLDING (SONVY) Switzerland $19.328B 0.00
Hologic (HOLX) United States $14.433B 15.57
Fresenius Medical Care AG KGaA (FMS) Germany $13.462B 13.82
Penumbra (PEN) United States $11.675B 105.62
Sysmex ADR (SSMXY) Japan $11.519B 36.12
Globus Medical (GMED) United States $11.454B 26.79
Masimo (MASI) United States $9.488B 45.91
Glaukos (GKOS) United States $8.676B 0.00
Teleflex (TFX) United States $8.134B 12.97
Inari Medical (NARI) United States $4.682B 0.00
Integer Holdings (ITGR) United States $4.536B 25.51
PROCEPT BioRobotics (PRCT) United States $3.412B 0.00
Veracyte (VCYT) United States $3.181B 95.46
Nihon Kohden (NHNKY) Japan $2.671B 14.60
LivaNova (LIVN) United Kingdom $2.606B 15.04
TransMedics (TMDX) United States $2.532B 80.27
Elekta AB (EKTAY) Sweden $2.336B 21.00
Tandem Diabetes Care (TNDM) United States $2.110B 0.00
Integra LifeSciences Holdings (IART) United States $1.700B 8.88
Alphatec Holdings (ATEC) United States $1.512B 0.00
Pulse Biosciences (PLSE) United States $1.230B 0.00
RxSight (RXST) United States $1.222B 0.00
Artivion (AORT) United States $1.208B 80.06
Paragon 28 (FNA) United States $1.093B 0.00
Beta Bionics (BBNX) United States $0.894B 0.00
AxoGen (AXGN) United States $0.814B 0.00
Mesa Laboratories (MLAB) United States $0.793B 17.33
SiBone (SIBN) United States $0.755B 0.00
IRadimed (IRMD) United States $0.724B 38.09
AVANOS MEDICAL, INC (AVNS) United States $0.711B 12.09
ORTHOFIX MEDICAL INC (OFIX) United States $0.692B 0.00
Treace Medical Concepts (TMCI) United States $0.602B 0.00
OrthoPediatrics (KIDS) United States $0.590B 0.00
Delcath Systems (DCTH) United States $0.497B 0.00
Semler Scientific (SMLR) United States $0.484B 10.64
ClearPoint Neuro (CLPT) United States $0.481B 0.00
Pacific Biosciences Of California (PACB) United States $0.449B 0.00
AngioDynamics (ANGO) United States $0.429B 0.00
NeuroPace (NPCE) United States $0.425B 0.00
CVRx (CVRX) United States $0.365B 0.00
Tactile Systems Technology (TCMD) United States $0.363B 19.47
Anteris Technologies Global (AVR) Australia $0.297B 0.00
Inogen (INGN) United States $0.245B 0.00
Accuray (ARAY) United States $0.222B 0.00
Nevro (NVRO) United States $0.215B 0.00
Alpha Tau Medical (DRTS) Israel $0.201B 0.00
KORU Medical Systems (KRMD) United States $0.178B 0.00
Rapid Micro Biosystems (RPID) United States $0.158B 0.00
Neuronetics (STIM) United States $0.146B 0.00
Sight Sciences (SGHT) United States $0.140B 0.00
Spectral Diagnostics (EDTXF) Canada $0.129B 0.00
LENSAR (LNSR) United States $0.115B 0.00
Atossa Genetics (ATOS) United States $0.106B 0.00
EDAP TMS S.A (EDAP) France $0.101B 0.00
908 Devices (MASS) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.091B 13.90
Lucid Diagnostics (LUCD) United States $0.088B 0.00
Vicarious Surgical (RBOT) United States $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.083B 0.00
InspireMD (NSPR) Israel $0.081B 0.00
Hyperfine (HYPR) United States $0.078B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Covalon Technologies (CVALF) Canada $0.062B 32.14
Positron (POSC) United States $0.059B 0.00
Microbot Medical (MBOT) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.040B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Precision Optics (POCI) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Adagio Medical Holdings (ADGM) United States $0.023B 0.00
WORK Medical Technology Group (WOK) China $0.020B 0.00
Biosig Technologies (BSGM) United States $0.014B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Aspira Women's Health (AWH) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00